Tariq U Azam - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Tariq U Azam

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Journal of the American Heart Association|December 10, 2021

Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19Michael Pan, Alexi Vasbinder, Elizabeth Anderson, et al.

Journal of the American Society of Nephrology : JASN|September 23, 2020

Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKITariq U Azam, Husam R Shadid, Pennelope Blakely, et al.

BMJ (Clinical Research Ed.)|October 1, 2020

In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort studySalim S Hayek, Samantha K Brenner, Tariq U Azam, et al.

Diabetes Care|January 19, 2022

Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19Alexi Vasbinder, Elizabeth Anderson, Husam Shadid, et al.

Journal of the American Heart Association|August 4, 2022

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19Shengyuan Luo, Alexi Vasbinder, Jeanne M Du-Fay-de-Lavallaz, et al.

Journal of Medical Virology|January 18, 2024

SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID-19: The International Study of Inflammation in COVID-19Alexi Vasbinder, Kishan Padalia, Ian Pizzo, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Journal of the American Heart Association|December 10, 2021

Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19Michael Pan, Alexi Vasbinder, Elizabeth Anderson, et al.

Journal of the American Society of Nephrology : JASN|September 23, 2020

Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKITariq U Azam, Husam R Shadid, Pennelope Blakely, et al.

BMJ (Clinical Research Ed.)|October 1, 2020

In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort studySalim S Hayek, Samantha K Brenner, Tariq U Azam, et al.

Diabetes Care|January 19, 2022

Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19Alexi Vasbinder, Elizabeth Anderson, Husam Shadid, et al.

Journal of the American Heart Association|August 4, 2022

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19Shengyuan Luo, Alexi Vasbinder, Jeanne M Du-Fay-de-Lavallaz, et al.

Journal of Medical Virology|January 18, 2024

SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID-19: The International Study of Inflammation in COVID-19Alexi Vasbinder, Kishan Padalia, Ian Pizzo, et al.

Pageof 2